Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06067295

Enrollment

300

Registered

2023-10-04

Start date

2023-02-21

Completion date

2027-12-31

Last updated

2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Carcinoma

Brief summary

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Detailed description

PRIMARY OBJECTIVE: I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer. OUTLINE: This is an observational study. Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men of all racial and ethnic groups 18 years of age or older * Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy) * Prior participation on clinical trials is allowed

Exclusion criteria

* Inability to give informed consent * Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer

Design outcomes

Primary

Measure	Time frame	Description
Collection of biological specimens and clinical data for future research related to prostate cancer.	Up to 5 years	The objective of this study is to create a biorepository of biospecimen and clinical data. There is no primary clinical outcome for this study.

Countries

United States

Contacts

CONTACTCheryl Kefauver, RN

Cheryl.Kefauver@med.usc.edu323-865-0459

PRINCIPAL_INVESTIGATORAmir Goldkorn, MD

University of Southern California

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026